Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy

OBJECTIVES: We previously described adoptive immunotherapy (AIT) with cytotoxic T lymphocytes (CTLs) stimulated by the mucin 1 (MUC1)–expressing human pancreatic cancer cell line YPK-1 (MUC1-CTLs) and demonstrated that MUC1-CTLs might prevent liver metastasis. In the present study, we combined gemci...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsui, Hiroto, Hazama, Shoichi, Sakamoto, Kazuhiko, Shindo, Yoshitaro, Kanekiyo, Shinsuke, Nakashima, Masao, Matsukuma, Satoshi, Tokuhisa, Yoshihiro, Iida, Michihisa, Suzuki, Nobuaki, Yoshimura, Kiyoshi, Takeda, Shigeru, Ueno, Tomio, Yoshino, Shigefumi, Oka, Masaaki, Nagano, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555975/
https://www.ncbi.nlm.nih.gov/pubmed/28697053
http://dx.doi.org/10.1097/MPA.0000000000000880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555975/
https://www.ncbi.nlm.nih.gov/pubmed/28697053
http://dx.doi.org/10.1097/MPA.0000000000000880

Ejemplares similares